Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators
Open Access
- 1 March 2005
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 10 (2) , 157-167
- https://doi.org/10.1177/1087057104272295
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Potential mechanisms for the enhancement of HERG K+ channel function by phospholipid metabolitesBritish Journal of Pharmacology, 2004
- Drug binding to HERG channels: evidence for a ‘non‐aromatic’ binding site for fluvoxamineBritish Journal of Pharmacology, 2003
- High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage ClampASSAY and Drug Development Technologies, 2003
- Interleukin-13 in asthmaCurrent Opinion in Pulmonary Medicine, 2003
- The lineage decisions of helper T cellsNature Reviews Immunology, 2002
- Signaling and Transcription in T Helper DevelopmentAnnual Review of Immunology, 2000
- Prediction of Physicochemical Parameters by Atomic ContributionsJournal of Chemical Information and Computer Sciences, 1999
- Regulation of interferon-γ production by IL-12 and IL-18Current Opinion in Immunology, 1998
- A Combined Assay of Cell Viability and in Vitro Cytotoxicity with a Highly Water-Soluble Tetrazolium Salt, Neutral Red and Crystal Violet.Biological & Pharmaceutical Bulletin, 1996
- Role of iron in T cell activation: Th1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IGG mabs against the transferrin receptor and the iron chelator deferoxamineCellular Immunology, 1991